Many of the tests of the efficacy of hydroxychloriquine are not combining the drug with zinc, which doctors say is essential for the best results. From Joseph Berry at conservativewoman.co.uk:
MYSTERY surrounds why an anti-malaria drug is not being tested as a Covid-19 treatment in combination with zinc, which doctors say is crucial for efficacy.
As we reported recently, President Trump revealed he was taking hydroxychloroquine (HCQ) alongside zinc after reports that many doctors are doing the same to help ward off Covid-19.
Criticism of the President rose sharply after a non-randomised study published in the Lancet said that HCQ provided no benefit to hospitalised Covid-19 patients while being linked to increased deaths.
What the mainstream media did not point out is that the Lancet study failed to test HCQ with zinc. Other experts have found zinc to be vital for efficacy in this context.
Zinc, available as an over-the-counter supplement, has long been seen as an immune-system booster that helps develop immune cells, or antibodies, and can strengthen the body’s response to a virus.
American infectious disease specialist Joseph Rahimian explained that, in relation to Covid-19, zinc ‘does the heavy lifting and is the primary substance attacking the pathogen’. HCQ is said to work as a delivery systemfor zinc in fighting coronavirus.
Ironically, the Lancet study came out at the same time as it was reported that India’s premier health body had expanded use of HCQ as a preventive for key workers following three studies showing positive results.